Indian pharmaceutical market saw a late surge in June, with growth during the quarter primarily driven by cardiac, respiratory, CNS, and anti-diabetic therapies, said Emkay Global analysts.

Coriolis Pharma is investing $10 million to establish a research lab in Morrisville, North Carolina, creating 50 new jobs and ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares ...

With the sales of weight-loss drugs booming, India is now the epicentre of the global obesity treatment market, reports The ...

A prominent Liberian football club has officially changed its name from Global Pharma FC to Borough FC, following the withdrawal of its main sponsor. By: Christopher C. Walker, ...

In a vote of confidence for Virginia’s growing life sciences sector, pharmaceutical giant AstraZeneca announced plans to ...

Coriolis Pharma, headquartered in Martinsried, near Munich, Germany, has about 200 employees worldwide, according to reports.

British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump ...

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

AstraZeneca said it would invest $50 billion in U.S. production by 2030. At the core is a manufacturing plant to go somewhere in Virginia.